Vascular graft infection (VGI) is one of the most serious complications following arterial reconstructive surgery. VGI has received increasing attention over the past decade, but many questions remain regarding its diagnosis and management. In this review, we describe our approach to VGI through ...
Editor's Choice
The obligation to provide treatment to infectious patients has been debated by ethicists for the past century. In this review article, we found that ethics articles during COVID-19 were less likely to argue for a duty to treat.
Vascular graft infection (VGI) is one of the most serious complications following arterial reconstructive surgery. VGI has received increasing attention over the past decade, but many questions remain regarding its diagnosis and management. In this review, we describe our approach to VGI through multidisciplinary ...
Vascular graft infection (VGI) is one of the most serious complications following arterial reconstructive surgery. VGI has received increasing attention over the past decade, but many questions remain regarding its diagnosis and management. In this review, we describe our approach to VGI through multidisciplinary ...
In the Swiss HIV Cohort Study, replacing tenofovir alafenamide (TAF) with tenofovir disoproxil fumarate (TDF) resulted in a -1.84 kg weight decrease within one year. No substantial weight changes were noted after switching from TAF to dolutegravir/lamivudine or cabotegravir/rilpivirine.
Best of the IDSA Journals 2023
As we usher in the new year, the IDSA journals would like to thank all the excellent authors and peer reviewers that have contributed their expertise in 2023. The Editors-in-Chief of Clinical Infectious Diseases, The Journal of Infectious Diseases, and Open Forum Infectious Diseases have each selected 5 articles that represent significant contributions in their fields. We invite you to explore the sample of impressive research online.
CID Now Offers Review Pathway for Papers Rejected by High-Impact Journals
Clinical Infectious Diseases welcomes papers that have been peer reviewed by another medical journal and were not accepted for publication, where the authors believe they can address the essential concerns identified by previous reviewers. Under this new pathway, authors can revise the paper according to the review comments they previously received and then submit the paper to CID. This new pathway is intended to speed publication and minimize unnecessary re-review of papers that previously received thorough and detailed review elsewhere.
Society Members
For your free access to this journal, log in via the IDSA members area.
Email Alerts
Register for email alerts and get notified as soon a new issue of Clinical Infectious Diseases is published online. And, with the IDSA Journals app, it's easy to stay connected, giving you the freedom to read the journal both online and offline, on your iPad, iPhone, or iPod Touch.
IDSA Journals Now on X
X users can now follow all three IDSA journals to stay up to date and comment on the latest published articles, journal-related news, and announcements on special features and supplements.
